HPV legislation in Hawaii

Women in Government Ratings

Women in Government, a non-profit network of state level women legislators, receives significant funding from the pharmaceutical industry, including Merck, GlaxoSmithKline, and Digene Corporation -- all with products related to HPV vaccination and testing. According to their report, "The 'State' of Cervical Cancer Prevention in America - 2008" :

POPULATION: 1,285,498

Incidence & Mortality (2008 Score / 2007 Score)

• Cervical Cancer Incidence Rate: 6.3/100,000 (2 / 1)
• Cervical Cancer Incidence Rate/Race: White: 7.9, Asian/Pacific Islander: 6.3
• Cervical Cancer Mortality Rate: 2.4/100,000 (1 / 1)
• Cervical Cancer Mortality Rate/Race: White: 2.1, Asian/Pacific Islander: 2.5

Screening (2008 Score / 2007 Score)

• Cervical Cancer Screening Rate: 82.0% (1 / 1)
• Cervical Cancer Screening Rate/Race: White: 86.2, Hispanic: 83.2%%, Asian/Pacific Islander: 78.2%
• % Uninsured/Unscreened: 29.1% (1 / 1)
• Medicaid Coverage HPV Testing: Unrestricted (2 / 2)

Healthcare Access (2008 Score / 2007 Score)

• Rate Uninsured Women: 11% (1 / 1)
• % Low Income/Uninsured Women: 22%

Policy Initiatives and Infrastructure (2008 Score / Cumulative Score (2005–2008)

Screening Requirements (0 / 1)

• There are no new screening requirements.

Task Forces (0 / 1)

• There is no new cervical cancer prevention task force legislation.

Access to HPV Vaccines (1 / 1)

• HB 1000 would include the HPV vaccine in the Teen Vax Program for uninsured/underinsured girls age 11–18; carried over to 2008 session.
• HB 590 requires health insurance policies issued in the state to cover the HPV vaccine for people age 11–26; directs Dept. of Health to include HPV vaccine in Teen Vax Program; carried over to 2008 session.

HPV Vaccine Information Programs (0 / 0)

• There is no HPV vaccine information activity.

Miscellaneous (1 / 2)

• SR 137/SCR 213 and HR 160/HCR 202 request the governor to fund breast and cervical cancer screening for low-income women; passed.
• HB 459/SB 1108 would appropriate funding to the Dept. of Health and women’s caucus to conduct an educational program about the causesand prevention of cervical cancer; carried over to 2008 session.

Annual Ratings

• 2008: Good (13 out of 22 points)
• 2007: Good (11 out of 18 points)

Articles and resources

SourceWatch Resources

• Gardasil
• GlaxoSmithKline
• Merck
• Women in Government
• Edelman
• The Marketing of Gardasil in Australia
• The Marketing of Gardasil in Canada
• The Marketing of Gardasil in Europe
• The Marketing of Gardasil in New Zealand
• The Marketing of Gardasil in the United States
• Direct-to-consumer advertising
• Disease Mongering
• Drug industry

External links

• Judith Siers-Poisson, The Politics and PR of Cervical Cancer, a four part series, PRWatch.org, July, 2007.